Ghent University Academic Bibliography

Show Sort by

Your filters: cql: affiliation exact FW cql: author exact 800000045346

Add to list
An integrated paediatric population PK/PD analysis of dDAVP : how do PK differences translate to clinical outcomes?

Robin Michelet (UGent) , Lien Dossche (UGent) , Charlotte Van Herzeele (UGent) , Pauline De Bruyne (UGent) , Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , Johan Vande Walle (UGent) and An Vermeulen (UGent)

(2020) CLINICAL PHARMACOKINETICS. 59(1). p.81-96
Add to list
- Conference Paper
- C3
SAFEPEDRUG : safer pediatric drugs for children: what have we learned?

Elke Gasthuys (UGent) , Johan Vande Walle (UGent) , Lien Dossche (UGent) , Lieve Nuytinck (UGent) , Robin Michelet, An Vermeulen (UGent) and Sevasti Karamaria (UGent)

(2019) Belgian Association of Pediatricians, 47th Annual conference, Abstracts.
Add to list
PBPK and its virtual populations : the impact of physiology on pediatric pharmacokinetic predictions of tramadol

Huybrecht T'jollyn (UGent) , An Vermeulen (UGent) and Jan Van Bocxlaer (UGent)

(2019) AAPS JOURNAL. 21(1).
Add to list
A semiphysiological population pharmacokinetic model of agomelatine and its metabolites in Chinese healthy volunteers

Feifan Xie (UGent) , An Vermeulen (UGent) , Pieter Colin (UGent) and Zeneng Cheng

(2019) BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 85(5). p.1003-1014
Add to list
Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice.

Feifan Xie (UGent) , Kaat De Clercq (UGent) , Chris Vervaet (UGent) , Jan Van Bocxlaer (UGent) , Pieter Colin (UGent) and An Vermeulen (UGent)

(2019) PHARMACEUTICAL RESEARCH. 36(9).
Add to list
- Journal Article
- A1
- open access
A dried blood spot assay for paclitaxel and its metabolites

Feifan Xie (UGent) , Elien De Thaye (UGent) , An Vermeulen (UGent) , Jan Van Bocxlaer (UGent) and Pieter Colin (UGent)

(2018) JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 148. p.307-315
Add to list
- Journal Article
- A1
- open access
Population pharmacokinetic modeling of a desmopressin oral lyophilisate in growing piglets as a model for the pediatric population

Elke Gasthuys (UGent) , An Vermeulen (UGent) , Siska Croubels (UGent) , Joske Millecam (UGent) , Stijn Schauvliege (UGent) , Thomas van Bergen (UGent) , Pauline De Bruyne (UGent) , Johan Vande Walle (UGent) and Mathias Devreese (UGent)

(2018) FRONTIERS IN PHARMACOLOGY. 9.
Add to list
A physiologically based pharmacokinetic perspective on the clinical utility of albumin-based dose adjustments in critically ill patients

Huybrecht T'jollyn (UGent) , An Vermeulen (UGent) , Jan Van Bocxlaer (UGent) and Pieter Colin (UGent)

(2018) CLINICAL PHARMACOKINETICS. 57(1). p.59-69
Add to list
Claiming desmopressin therapeutic equivalence in children requires pediatric data : a population PKPD analysis

Robin Michelet (UGent) , Lien Dossche (UGent) , Charlotte Van Herzeele (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Johan Vande Walle (UGent)

(2018) EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 74(3). p.297-305
Add to list
- Conference Paper
- C3
A model-based analysis of the kinetics of leukocytes in stage III ovarian cancer patients treated with neo-adjuvant chemotherapy, cytoreductive surgery and cisplatin-based intraperitoneal chemoperfusion

Feifan Xie (UGent) , Charlotte Carlier (UGent) , Wim Ceelen (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Pieter Colin (UGent)

(2018) In PAGE (LEIDEN) 27.

Academic Bibliography

An integrated paediatric population PK/PD analysis of dDAVP : how do PK differences translate to clinical outcomes?

SAFEPEDRUG : safer pediatric drugs for children: what have we learned?

PBPK and its virtual populations : the impact of physiology on pediatric pharmacokinetic predictions of tramadol

A semiphysiological population pharmacokinetic model of agomelatine and its metabolites in Chinese healthy volunteers

Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice.

A dried blood spot assay for paclitaxel and its metabolites

Population pharmacokinetic modeling of a desmopressin oral lyophilisate in growing piglets as a model for the pediatric population

A physiologically based pharmacokinetic perspective on the clinical utility of albumin-based dose adjustments in critically ill patients

Claiming desmopressin therapeutic equivalence in children requires pediatric data : a population PKPD analysis

A model-based analysis of the kinetics of leukocytes in stage III ovarian cancer patients treated with neo-adjuvant chemotherapy, cytoreductive surgery and cisplatin-based intraperitoneal chemoperfusion

Contents

Support

Contact